Could stem cells offer a viable treatment for retinopathy?

BetaStem Therapeutics research outreach

Diabetes is a growing global epidemic, with over 400 million affected and cases expected to double in the next 10 years. Retinopathy, or damage to the blood vessels in the retina, occurs in most patients with type 1 diabetes and 75 per cent of patients with type 2 diabetes, leading to vision loss for many. BetaStem Therapeutics is a stem […]

Read More…